Clinical Trial Update: A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure [Phase 3]

View source ↗

Summary

This update reports results from a Phase 3 study evaluating the impact of canagliflozin on health status, quality of life, and functional status in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2023-01-12